Abstract:
:Selection of dose for cancer patients treated with radiation therapy (RT) must balance the increased efficacy with the increased toxicity associated with higher dose. Historically, a single dose has been selected for a population of patients (e.g., all stage III non-small cell lung cancer). However, the availability of new biologic markers for toxicity and efficacy allows the possibility of selecting a more personalized dose. We consider the use of statistical models for toxicity and efficacy as a function of RT dose and biomarkers to select an optimal dose for an individual patient, defined as the dose that maximizes the probability of efficacy minus the sum of weighted toxicity probabilities. This function can be shown to be equal to the expected value of the utility derived from a particular family of bivariate outcome utility matrices. We show that if dose is linearly related to the probability of toxicity and efficacy, then any marker that only acts additively with dose cannot improve efficacy, without also increasing toxicity. Using a dataset of lung cancer patients treated with RT, we illustrate this approach and compare it to non-marker-based dose selection. Because typical metrics used in evaluating new markers (e.g., area under the ROC curve) do not directly address the ability of a marker to improve efficacy at a fixed probability of toxicity, we utilize a simulation study to assess the effects of marker-based dose selection on toxicity and efficacy outcomes.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Schipper MJ,Taylor JM,TenHaken R,Matuzak MM,Kong FM,Lawrence TSdoi
10.1002/sim.6285subject
Has Abstractpub_date
2014-12-30 00:00:00pages
5330-9issue
30eissn
0277-6715issn
1097-0258journal_volume
33pub_type
杂志文章abstract::Prognostic models are used in medicine for investigating patient outcome in relation to patient and disease characteristics. Such models do not always work well in practice, so it is widely recommended that they need to be validated. The idea of validating a prognostic model is generally taken to mean establishing tha...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000229)19:4<453::aid-sim
更新日期:2000-02-29 00:00:00
abstract::Clinical trials, especially the randomized clinical trial, have been and will remain the gold standard for the evaluation of new interventions, including pharmaceuticals, biologics, medical devices, procedures, or behavioral modifications. Despite more than five decades of experience, there are still challenges in the...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5405
更新日期:2012-11-10 00:00:00
abstract::Disease incidence predictions are useful for a number of administrative and scientific purposes. The simplest ones are made using trend extrapolation, on either an arithmetic or a logarithmic scale. This paper shows how approximate confidence prediction intervals can be calculated for such predictions, both for the to...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780131503
更新日期:1994-08-15 00:00:00
abstract::In the pharmaceutical industry, some tests for quality assurance before, during and after the manufacture of a drug product involve a two-stage sampling technique. We propose statistical testing procedures in a two-stage sampling problem with large within-class sample sizes. We also derive a two-stage sampling plan by...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780122104
更新日期:1993-11-15 00:00:00
abstract::The power prior has been widely used in many applications covering a large number of disciplines. The power prior is intended to be an informative prior constructed from historical data. It has been used in clinical trials, genetics, health care, psychology, environmental health, engineering, economics, and business. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6728
更新日期:2015-12-10 00:00:00
abstract::The design of a cross-sectional survey to estimate the age-specific incidence of an irreversible disease is considered, where the incidence rate is not changing over time and the risk of mortality is not affected by the onset of disease. The sample is assumed to give information on the current age and disease status o...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780132208
更新日期:1994-11-30 00:00:00
abstract::In different fields of applications including, but not limited to, behavioral, environmental, medical sciences, and econometrics, the use of panel data regression models has become increasingly popular as a general framework for making meaningful statistical inferences. However, when the ordinary least squares (OLS) m...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8732
更新日期:2020-12-20 00:00:00
abstract::Group sequential testing procedures have been proposed as an approach to conserving resources in biomarker validation studies. Previously, we derived the asymptotic properties of the sequential empirical positive predictive value (PPV) and negative predictive value (NPV) curves, which summarize the predictive accuracy...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6790
更新日期:2016-04-15 00:00:00
abstract::The change in c-statistic is frequently used to summarize the change in predictive accuracy when a novel risk factor is added to an existing logistic regression model. We explored the relationship between the absolute change in the c-statistic, Brier score, generalized R(2) , and the discrimination slope when a risk f...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5598
更新日期:2013-02-20 00:00:00
abstract::Researchers in clinical science and bioinformatics frequently aim to learn which of a set of candidate biomarkers is important in determining a given outcome, and to rank the contributions of the candidates accordingly. This article introduces a new approach to research questions of this type, based on targeted maximu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3414
更新日期:2009-01-15 00:00:00
abstract::Although hypertension is regarded as a causal factor for coronary heart disease (CHD) a reduction in the risk of CHD as a result of lowering blood pressure in mild hypertension could not be demonstrated. This conclusion is based on an overview analysis of all published randomized trials in mild hypertension, including...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780071104
更新日期:1988-11-01 00:00:00
abstract::Exposure to a carcinogen is likely to be reflected by temporal clustering of cancer cases among the community members. Detection of such clustering is a complicated task in general and more so in a small workplace community with low turnover rate. In this study we applied the CUSCORE test and the q-interval statistic ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1534
更新日期:2003-10-15 00:00:00
abstract::In observational cohort studies we may wish to examine the associations between fixed patient characteristics and the longitudinal changes from baseline in a repeated outcome measure. Many biological and other outcome measures are known to be subject to measurement error and biological variation. In an initial analysi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3725
更新日期:2009-11-20 00:00:00
abstract::Crossover studies have been successfully conducted in the case of continuous responses. Existing procedures of analysis for ordinal responses, on the other hand, are rarely satisfactory unless strict, usually unrealistic, assumptions are made. In this paper we investigate a random effects model and show that the model...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780100611
更新日期:1991-06-01 00:00:00
abstract::In many studies, interest lies in determining whether members of the study population will undergo a particular event of interest. Such scenarios are often termed 'mover-stayer' scenarios, and interest lies in modelling two sub-populations of 'movers' (those who have a propensity to undergo the event of interest) and ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5529
更新日期:2013-02-20 00:00:00
abstract::While there has been extensive research developing gene-environment interaction (GEI) methods in case-control studies, little attention has been given to sparse and efficient modeling of GEI in longitudinal studies. In a two-way table for GEI with rows and columns as categorical variables, a conventional saturated int...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6281
更新日期:2014-12-20 00:00:00
abstract::Repeated cross-sectional samples are common in national surveys of health like the National Health Interview Survey (NHIS). Because population health outcomes generally evolve slowly, pooling data across years can improve the precision of current-year annual estimates of disease prevalence and other health outcomes. P...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3897
更新日期:2011-02-28 00:00:00
abstract::Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control. An increasing desire to reduce the time before regulatory approval of a new drug is sought has led to development of two-stage or sequential designs for trials that combine the defini...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1362
更新日期:2003-03-15 00:00:00
abstract::In the analysis of survival data, there are often competing events that preclude an event of interest from occurring. Regression analysis with competing risks is typically undertaken using a cause-specific proportional hazards model. However, modern alternative methods exist for the analysis of the subdistribution haz...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4123
更新日期:2011-03-15 00:00:00
abstract::Correct specification of the inverse probability weighting (IPW) model is necessary for consistent inference from a marginal structural Cox model (MSCM). In practical applications, researchers are typically unaware of the true specification of the weight model. Nonetheless, IPWs are commonly estimated using parametric...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7266
更新日期:2017-06-15 00:00:00
abstract::In many practical applications, count data often exhibit greater or less variability than allowed by the equality of mean and variance, referred to as overdispersion/underdispersion, and there are several reasons that may lead to the overdispersion/underdispersion such as zero inflation and mixture. Moreover, if the c...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5560
更新日期:2013-04-15 00:00:00
abstract::Meta analysis is a collection of quantitative methods devoted to combine summary information from related but independent studies. Because research reports usually present only data reductions and summary statistics rather than detailed data, the reviewer must often resort to rather crude methods for constructing summ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2287
更新日期:2006-07-15 00:00:00
abstract::The analysis and recognition of disease clustering in space and its representation on a map is an important problem in epidemiology. An approach using mixture models to identify spatial heterogeneity in disease risk and map construction within an empirical Bayes framework is described. Once heterogeneity is detected, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19960415)15:7/9<919::aid-s
更新日期:1996-04-15 00:00:00
abstract::Meta-analysis has generally been accepted as a fundamental tool for combining effect estimates from several studies. For binary studies with rare events, the Peto odds ratio (POR) method has become the relative effect estimator of choice. However, the POR leads to biased estimates for the OR when treatment effects are...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6301
更新日期:2014-12-10 00:00:00
abstract::It is often of interest to use observational data to estimate the causal effect of a target exposure or treatment on an outcome. When estimating the treatment effect, it is essential to appropriately adjust for selection bias due to observed confounders using, for example, propensity score weighting. Selection bias du...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8549
更新日期:2020-08-15 00:00:00
abstract::Both the variation of positive responses (negative responses) among individuals and the internal correlation among responses for the same individual affect the precision of the estimate of sensitivity (specificity). To estimate the sensitivity (specificity) of a medical diagnostic test, this paper proposes a Bayesian ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780081007
更新日期:1989-10-01 00:00:00
abstract::Three-arm trials including the experimental treatment, an active reference treatment and a placebo are recommended in the guidelines of the ICH and EMEA/CPMP as a useful approach to the assessment of assay sensitivity. Generally, the acceptable non-inferiority margin Δ has been defined as the maximum clinically irrele...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4099
更新日期:2011-02-10 00:00:00
abstract::Sample size planning should reflect the primary objective of a trial. If the primary objective is prediction, the sample size determination should focus on prediction accuracy instead of power. We present formulas for the determination of training set sample size for survival prediction. Sample size is chosen to contr...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5550
更新日期:2013-02-28 00:00:00
abstract::This article deals with determination of a sample size that guarantees the success of a trial. We follow a Bayesian approach and we say an experiment is successful if it yields a large posterior probability that an unknown parameter of interest (an unknown treatment effect or an effects-difference) is greater than a c...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3175
更新日期:2008-06-15 00:00:00
abstract::Observational cohort studies often feature longitudinal data subject to irregular observation. Moreover, the timings of observations may be associated with the underlying disease process and must thus be accounted for when analysing the data. This paper suggests that multiple outputation, which consists of repeatedly ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6829
更新日期:2016-05-20 00:00:00